EZH2 and glioblastoma: Our previous study has shown that DNMT3A, EED, and EZH2 are direct targets of miR-101 in GBM cells, and histone methylation modification and DNA methyltransferase are critical factors that regulate gene promoter methylation (43–46, 54).